Tectonic Therapeutic | AVRO - Loan Capital

Stock Price
27.10
Daily Change
-0.10 -0.37%
Monthly
-6.13%
Yearly
29.91%
Q2 Forecast
27.93

Tectonic Therapeutic reported $43K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Gilead Sciences USD 22.13B 6M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 70M 256K Dec/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 57.41B 93M Sep/2025
Pharma Mar EUR 36.68M 1.07M Dec/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 13.84B 1.88B Mar/2026
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.27T 81.29B Dec/2025
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025